KRCA-0008

Overview

KRCA-0008 is a selective ALK/Ack1 inhibitor with IC 50 s of 12 and 4 nM for ALK and Ack1 , respectively. KRCA-0008 can be used for the research of cancer .

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Urogenital Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Ack1 | Products > Signaling Pathways > Anaplastic lymphoma kinase (ALK) | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-12331
• CAS No.: 1472795-20-2
• Molecular Formula: C30H37ClN8O4
• Molecular Weight: 609.12
• Purity: 96.19%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5.75 mg/mL (9.44 mM); Clear solution
• Availability: In-stock

Source

Original product source